Gore has announced the first patient implant of conformable thoracic stent graft with Active Control System after receiving CE mark last month. The first implant was performed by Giovanni Torsello and Martin Austermann at St. Franziskus Hospital, Munster, Germany. The new device will be formally launched in European regions later this year.
The Gore Viatorr TIPS endoprosthesis with Controlled Expansion, a new device configuration developed by Gore, may reduce portal hypertension treatment complications, even when compared to the Gore Viatorr TIPS endoprosthesis, Gore’s legacy TIPS device. The latter has a strong history of patency and proven performance at fixed diameters. These findings were obtained from the abstract presented at The International Liver Congress 2017 in Amsterdam.
The Montpellier University Hospital (Montpellier, France) has inaugurated an avant-garde interventional radiology intervention room in the Department of Interventional Radiology at the St-Eloi Hospital.
Medtronic has announced recent reimbursement approvals in both France and Belgium.
Johnson and Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July, Colorado Springs, USA).
The Journal of Vascular and Interventional Radiology’s (JVIR’s) impact factor—one measure of a journal’s influence based on the number of article citations compared to the total number of articles published—increased by 8.2% in 2016.
The 24-month results of the worldwide experience with Lutonix 035 drug-coated balloon (CR Bard/Beckton Dickenson) were published online in August in JACC: Cardiovascular Interventions. Data revealed that patients with femoropopliteal lesions who were treated with the drug-coated balloon experienced symptom improvement and that low reintervention rates were observed at 24 months, even in patients with difficult-to-treat lesions.
Merit Medical will partner with internationally renowned interventional cardiologist Ferdinand Kiemeneij to deliver the next generation in educational opportunities for interventional cardiologists and interventional radiologists. Kiemeneij will serve as a co-proctor at the upcoming Advanced Transradial Intervention Education Course for Interventional Cardiologists (13–14 October, Merit Medical Education Cente, Salt Lake City, USA).
Medtronic has announced its intent to move forward with a new renal denervation pivotal trial following positive first results from a sham-controlled study in patients with high blood pressure. Investigators of the SPYRAL HTN-OFF MED Study found statistically significant and clinically important blood pressure reductions in the patients treated with renal denervation across both office and ambulatory systolic and diastolic measurements. The data in the first 80 patients enrolled in the study at three months were presented in a late-breaking clinical trial session at the European Society of Cardiology (ESC) meeting in Barcelona, Spain and published simultaneously in The Lancet.
A new study is underway at Emory Healthcare, Atlanta, USA, to evaluate the use of cryoablation to treat mild to moderate obesity.
Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial details of the transaction will not be disclosed.
Philips has announced that it has completed the acquisition of The Spectranetics Corporation, a US-based global leader in vascular intervention and lead management solutions. Spectranetics’ financial results will be consolidated as part of Philips’ Image-Guided Therapy business group as of 9 August 2017.
Royal Philips and The Spectranetics Corporation announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a tender offer to acquire all of the issued and outstanding shares of Spectranetics for US$38.50 per share, to be paid in cash upon completion.
Philips has announced the relaunch of the Pioneer Plus catheter, described as the only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment designed to assist arterial vessel intervention.
Interventional radiologists at the Emory Johns Creek Hospitals (EJCH), Johns Creek, USA, are using radiofrequency ablation to reduce pain for cancer patients.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos